In patients with rheumatoid arthritis, decreased abundance of the N-myristoyltransferase NMT1 in CD4+ T cells prevents N-myristoylation of the AMP-activated protein kinase AMPK and its localization to the lysosomal membrane, which leads to increased activation of the metabolic checkpoint kinase complex mTORC1 and proinflammatory T cell phenotypes.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Udenwobele, D. I. et al. Front. Immunol. 8, 751 (2017).
Wen, Z. et al. Nat. Immunol. https://doi.org/10.1038/s41590-018-0296-7 (2019).
Rampoldi, F. et al. J. Immunol. 195, 4228–4243 (2015).
Weyand, C. M., Zeisbrich, M. & Goronzy, J. J. Curr. Opin. Immunol. 46, 112–120 (2017).
Oakhill, J. S. et al. Proc. Natl Acad. Sci. USA 107, 19237–19241 (2010).
Zhang, C. S. et al. Cell Metab. 20, 526–540 (2014).
Lin, S. C. & Hardie, D. G. Cell Metab. 27, 299–313 (2018).
Bruyn, G. A. et al. Ann. Rheum. Dis. 67, 1090–1095 (2008).
Deng, L. et al. Cell Death Dis. 9, 1143 (2018).
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Finlay, D.K. N-myristoylation of AMPK controls T cell inflammatory function. Nat Immunol 20, 252–254 (2019). https://doi.org/10.1038/s41590-019-0322-4
This article is cited by
N-myristoylation: from cell biology to translational medicine
Acta Pharmacologica Sinica (2020)